Lazard Asset Management LLC Haemonetics Corp Transaction History

Lazard Asset Management LLC

$72.9 Billion
Q2 2024

A detailed history of Lazard Asset Management LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 8,457 shares of HAE stock, worth $670,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,457

Previous 10,368 18.43%

Holding current value

$670,724

Previous $884,000 20.93%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $155,249 - $186,074	-1,911 Reduced 18.43%	8,457 $699,000
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $1.86 Million - $2.23 Million	-26,088 Reduced 71.56%	10,368 $884,000
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $167,788 - $192,814	-2,082 Reduced 5.4%	36,456 $3.12 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $1.7 Million - $1.92 Million	20,550 Added 114.24%	38,538 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $2.06 Million - $2.28 Million	-25,441 Reduced 58.58%	17,988 $1.53 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $120,619 - $150,214	1,658 Added 3.97%	43,429 $3.59 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $160,476 - $187,182	-2,173 Reduced 4.94%	41,771 $3.29 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $2.78 Million - $3.46 Million	43,944 New	43,944 $3.25 Million
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $1.85 Million - $2.67 Million	-42,306 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$49.55 - $74.59 $2.09 Million - $3.15 Million	42,259 Added 89912.77%	42,306 $2.24 Million
Q2 2021 Aug 12, 2021	SELL	$51.81 - $118.56 $1.74 Million - $3.98 Million	-33,598 Reduced 99.86%	47 $3,000
Q1 2021 May 14, 2021	BUY	$111.01 - $139.48 $3.69 Million - $4.63 Million	33,222 Added 7853.9%	33,645 $3.73 Million
Q3 2020 Nov 13, 2020	BUY	$75.65 - $93.58 $14,146 - $17,499	187 Added 79.24%	423 $36,000
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $39,931 - $55,887	-470 Reduced 66.57%	236 $21,000
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $52,484 - $86,004	706 New	706 $70,000
Q1 2019 May 13, 2019	SELL	$83.25 - $102.12 $301,614 - $369,980	-3,623 Closed	0 $0
Q4 2018 Aug 28, 2019	SELL	$90.66 - $116.63 $2,538 - $3,265	-28 Reduced 0.77%	3,623 $362,000
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $281,680 - $362,369	3,107 Added 571.14%	3,651 $364,000
Q3 2018 Aug 30, 2019	SELL	$89.96 - $114.58 $2,518 - $3,208	-28 Reduced 4.9%	544 $62,000
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $340,138 - $433,226	-3,781 Reduced 86.86%	572 $65,000
Q2 2018 Aug 30, 2019	SELL	$71.53 - $95.75 $2,932 - $3,925	-41 Reduced 0.93%	4,353 $390,000
Q2 2018 Aug 13, 2018	SELL	$71.53 - $95.75 $221,671 - $296,729	-3,099 Reduced 41.36%	4,394 $394,000
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $168,315 - $206,264	2,772 Added 58.72%	7,493 $548,000
Q4 2017 Feb 13, 2018	BUY	$44.96 - $58.99 $212,256 - $278,491	4,721	4,721 $274,000

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.07B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Haemonetics Corp Transaction History